GALDERMA RESEARCH & DEVELOPMENT
🏢 View company profile →251Patents
201Active
251Granted
56Portfolio score
Filing activity: Dec 31, 1997 → Dec 15, 2020 · 78 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6340495B1 | Device including a chromophoric composition to be applied to the skin, a method of fabricating such a device, and uses therefor | Human Necessities | 49 | Expired |
| US6803382B2 | Angiogenesis inhibitors and pharmaceutical and cosmetic use thereof | Chemistry; Metallurgy | 49 | Expired |
| US6689922B1 | Vitamin D analogues | Chemistry; Metallurgy | 26 | Expired |
| US9271930B2 | Dermatological foams obtained from a gel or suspension containing adapalene | Human Necessities | 25 | Active |
| US6214878A | Stilbene compounds comprising an adamantyl group, compositions and methods thereof | Chemistry; Metallurgy | 25 | Expired |
| US6403656B1 | Use of ppar-&ggr; activators in dermatology | Human Necessities | 25 | Expired |
| US6927228B2 | Biaromatic compound activators of PPARγ-type receptors | Human Necessities | 22 | Expired |
| US6127415A | Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents | Human Necessities | 21 | Expired |
| US6462064B1 | Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias | Human Necessities | 16 | Expired |
| US7642288B2 | Topical application of adapalene for the long-term treatment of acne vulgaris | Human Necessities | 15 | Active |
| US7964202B2 | Method for treatment of common acne | Human Necessities | 15 | Active |
| US6908939B2 | Biaromatic ligand activators of PPARγ receptors | Human Necessities | 14 | Expired |
| US7579377B2 | Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders | Chemistry; Metallurgy | 12 | Active |
| US9050246B2 | Injectable combination of adrenergic receptor agonists with fillers, for decreasing skin reactions due to injection | Human Necessities | 11 | Active |
| US7820186B2 | Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt | Human Necessities | 11 | Expired |
| US6831106B1 | Vitamin D analogues | Emerging Cross-Sectional Technologies | 10 | Expired |
| US8784905B2 | Oil-extracted product of indigo naturalis, and preparation process and uses thereof | Human Necessities | 10 | Active |
| US10857123B2 | NLRP3 inhibitors for the treatment of inflammatory skin disorders | Human Necessities | 10 | Active |
| US6706725B1 | Vitamin D analogues | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6028114A | Use of aminothiolester derivatives in pharmaceutics | Human Necessities | 8 | Expired |
| US8445543B2 | Combinations of adapalene and benzoyl peroxide for treating acne lesions | Human Necessities | 7 | Active |
| US8957112B2 | Cream gels comprising at least one retinoid and benzoyl peroxide | Human Necessities | 7 | Active |
| US8568704B2 | Dermatological/pharmaceutical compositions comprising benzoyl peroxide, at least one naphthoic acid compound and at least one polyurethane polymer | Human Necessities | 7 | Active |
| US8105618B2 | Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide | Human Necessities | 6 | Active |
| US8729127B2 | Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders | Chemistry; Metallurgy | 6 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.